Detalles de la búsqueda
1.
Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry.
Rheumatology (Oxford)
; 63(3): 772-779, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37307082
2.
Efforts to Better Characterize "Antiphospholipid Antibody Nephropathy" for the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria: Renal Pathology Subcommittee Report.
J Rheumatol
; 51(2): 150-159, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37399462
3.
Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study.
Lab Invest
; 103(6): 100147, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37044248
4.
Controversies in the Management of Antiphospholipid Syndrome.
J Clin Rheumatol
; 29(5): e107-e112, 2023 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37478021
5.
The clinical significance of low complement levels in patients with catastrophic antiphospholipid syndrome: A descriptive analysis of 73 patients from the "Catastrophic antiphospholipid syndrome registry".
Lupus
; 31(10): 1218-1225, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35686348
6.
Risk of livedo with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
Lupus
; 31(13): 1595-1605, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36112747
7.
Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry").
Lupus
; 31(14): 1770-1776, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36206383
8.
16th International congress on antiphospholipid antibodies task force report on clinical manifestations of antiphospholipid syndrome.
Lupus
; 30(8): 1314-1326, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34039107
9.
COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION).
Lupus
; 30(14): 2276-2285, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34915764
10.
A Covid-19 Patient with Complement-Mediated Coagulopathy and Severe Thrombosis.
Pathobiology
; 88(1): 28-36, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33137805
11.
Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-Year Update.
Curr Rheumatol Rep
; 23(6): 45, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33932165
12.
16th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome.
Lupus
; 29(12): 1594-1600, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32819183
13.
16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends.
Lupus
; 29(12): 1571-1593, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33100166
14.
Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry.
Lupus
; 29(11): 1353-1363, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32703117
15.
Treatment of antiphospholipid syndrome beyond anticoagulation.
Clin Immunol
; 206: 53-62, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29510235
16.
Catastrophic Antiphospholipid Syndrome: Candidate Therapies for a Potentially Lethal Disease.
Annu Rev Med
; 68: 287-296, 2017 01 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-28099080
17.
Response to: Correspondence on 'ACR/EULAR antiphospholipid syndrome classification criteria' by Damoiseaux and van Beers.
Ann Rheum Dis
; 83(3): e7, 2024 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37989544
18.
Response to: Correspondence on '2023 ACR/EULAR antiphospholipid syndrome classification criteria' by Miro-Mur et al.
Ann Rheum Dis
; 83(3): e3, 2024 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37989545
19.
Response to: Correspondence on '2023 ACR/EULAR antiphospholipid syndrome classification criteria' by Tang et al.
Ann Rheum Dis
; 83(3): e5, 2024 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37989547
20.
Clinical Insights into Diffuse Alveolar Hemorrhage in Antiphospholipid Syndrome.
Curr Rheumatol Rep
; 21(10): 56, 2019 09 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31493005